droplet digital PCR (ddPCR)

Join Dr. Yann Jouvenot for this overview of Bio-Rad’s Droplet Digital PCR (ddPCR™) System. Learn about the principles, unique characteristics, and applications of the technology and find out how it can be used to complement existing techniques in gene expression studies and microRNA analysis.

From the origins of digital PCR in leukemia research to stopping HIV with novel polymers to better methods for fragment-based drug discovery, BioRadiations has covered some of the most exciting life science research stories of 2013. Now take a look back at these stories and more as we review the best pieces of the year.

In this webinar presented by Dr. Jennifer Berman, learn how Droplet Digital PCR (ddPCR™) technology uses a simple, cost-effective workflow to accurately and reproducibly assess copy number variations (CNVs) even in high-throughput settings.

This presentation by Dr. Dawne Shelton describes how Droplet Digital PCR (ddPCR™) can be used to measure circulating nucleic acids (cfDNA) and circulating tumor cells (CTCs) in blood and to detect rare tumorigenic mutations down to 0.01% or less in a high background of normal DNA. Techniques and methods discussed in this webinar will enable you to begin your own investigations.

Droplet Digital PCR (ddPCR™) has revolutionized infectious disease research, cancer biomarker and genomic variation analysis, and other fields. This webinar by Dr. George Karlin-Neumann provides an overview of the ddPCR concept and workflow and discusses recent journal publications showcasing the technology’s diverse applications.

Prof. Alec Morley, a pioneer in digital PCR, describes his use of Droplet Digital PCR (ddPCR™) technology to advance the diagnosis and treatment of leukemia. Morley and his colleagues at Flinders University and Medical Center in Adelaide, South Australia previously developed a digital PCR method for the early detection of residual acute lymphoblastic leukemia (ALL). Learn how Morley is now using Bio-Rad’s ddPCR technology to develop a diagnostic test for monitoring chronic myeloid leukemia.

In the early 1990s, researcher Alec Morley and his colleagues pioneered digital PCR techniques to measure acute lymphoblastic leukemia. Today, Morley is trying to develop a more accurate way to quantify chronic myeloid leukemia. Find out why he chose Bio-Rad’s Droplet Digital PCR technology for this effort.

In this webinar, Prof. Alexander Urban of the Stanford School of Medicine describes how his lab used the QX200™ Droplet Digital™ PCR System to investigate copy number variation (CNV) in induced pluripotent stem cells (iPSCs) that were being used to study the genetics of autism.

This presentation by Vicki Hwang details how UC Davis researchers used Droplet Digital PCR (ddPCR™) technology to determine copy number variation (CNV) and characterize the deletion endpoints of the region of chromosome 22 that is deleted in 22q11 deletion syndrome.

Bio-Rad’s PrimePCR probe assays gave researchers a powerful, reliable set of investigative tools utilizing SYBR® Green detection chemistry. Now Bio-Rad is adding a number of new assays to the PrimePCR portfolio, bringing the benefits of PrimePCR assays to many new applications for both real-time PCR and Droplet Digital™ PCR platforms.